The Long Run with Luke Timmerman
Un pódcast de Timmerman Report
173 Episodo
-
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader
Publicado: 26/7/2021 -
Ep94: Jenny Rooke on Investing in Biotech Tools
Publicado: 19/7/2021 -
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists
Publicado: 14/6/2021 -
Ep92: Brad Gray on Spatial Biology
Publicado: 1/6/2021 -
Ep91: Daphne Zohar on Biotech Entrepreneurship
Publicado: 3/5/2021 -
Ep90: James Sabry on Partnering Amid Scientific Abundance
Publicado: 19/4/2021 -
Ep89: Emily Leproust on DNA Synthesis at Scale
Publicado: 29/3/2021 -
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
Publicado: 15/3/2021 -
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
Publicado: 1/3/2021 -
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
Publicado: 9/2/2021 -
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants
Publicado: 20/1/2021 -
Ep84: Steve Paul on Treatments for Mental Health
Publicado: 22/12/2020 -
Ep83: David Lee on Impact in Pharmaceuticals
Publicado: 14/12/2020 -
Ep82: Andrew Farnum on Medicines From Unusual Traits
Publicado: 23/11/2020 -
Ep81: Simba Gill on Microbiome Therapies
Publicado: 12/11/2020 -
Ep80: Peter Kolchinsky on Pharma's Soul
Publicado: 28/10/2020 -
Ep79: Daphne Koller on Machine Learning for Drug Discovery
Publicado: 26/10/2020 -
Ep78: Pearl Huang on Exoneural Cancer Biology
Publicado: 13/10/2020 -
Ep77: Jennifer Petter on Drugging RNA Targets
Publicado: 29/9/2020 -
Ep76: Otello Stampacchia on Becoming a Biotech VC
Publicado: 8/9/2020
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
